XML 12 R33.htm IDEA: XBRL DOCUMENT v3.3.0.814
STOCK-BASED COMPENSATION (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Feb. 10, 2015
May. 12, 2014
Apr. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Assumptions used in estimating fair values of options granted [Abstract]              
Unrecognized stock compensation expense       $ 116   $ 116  
Unrecognized stock compensation expense period           1 year  
Selling, General and Administrative Expenses [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock-based compensation expense       $ 13 $ 76 $ 257 $ 399
2013 Equity Incentive Plan [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Common stock authorized for issuance (in shares)       2,600,000   2,600,000  
Common stock available for future issuance (in shares)       1,260,050   1,260,050  
2013 Equity Incentive Plan [Member] | Stock Options [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Options granted exercise right period           10 years  
Stockholder ownership classification, for exercise price conditions       10.00%   10.00%  
Grant date fair value $ 160 $ 24 $ 736        
Option awards vesting on the date of issuance, 1 year after issuance and 2 years after issuance, respectively 33.33% 33.33% 33.33%        
Stock options expiration date Feb. 10, 2025 May 12, 2024 Apr. 30, 2024        
Intrinsic value of shares exercised       $ 19 $ 25 $ 19 $ 25
Assumptions used in estimating fair values of options granted [Abstract]              
Expected volatility           101.00% 79.00%
Expected dividend yield           0.00% 0.00%
Weighted average risk-free interest rate           1.52% 1.81%
Expected life           5 years 6 months 5 years 6 months
Forfeiture rate           0.00% 0.00%
Number of Shares [Roll Forward]              
Outstanding, Beginning balance (in shares)           1,503,000  
Grants (in shares) 430,000 25,000 840,000     430,000  
Exercised (in shares)           (74,000) 28,934
Forfeited, cancelled or expired (in shares)           (671,000)  
Outstanding, Ending balance (in shares)       1,188,000   1,188,000  
Exercisable (in shares)       927,000   927,000  
Weighted Average Exercise Price [Roll Forward]              
Outstanding, Beginning balance (in dollars per share)           $ 0.85  
Grants (in dollars per share) $ 0.79 $ 1.24 $ 1.44     0.79  
Exercised (in dollars per share)           (0.30)  
Forfeited, cancelled or expired (in dollars per share)           0.92  
Outstanding, Ending balance (in dollars per share)       $ 0.82   0.82  
Exercisable (in dollars per share)       $ 0.76   $ 0.76  
Options, Additional Disclosures [Abstract]              
Outstanding, Remaining Contractual Life           6 years  
Exercisable, Remaining Contractual Life 2 years 2 years 2 years     5 years  
Outstanding, Aggregate Intrinsic Value       $ 0   $ 0  
Exercisable, Aggregate Intrinsic Value       $ 0   $ 0  
2013 Equity Incentive Plan [Member] | Stock Options [Member] | Minimum [Member]              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
10% Stockholder exercise price of any option to fair value of common shares       110.00%   110.00%